全文获取类型
收费全文 | 4892篇 |
免费 | 349篇 |
国内免费 | 29篇 |
专业分类
耳鼻咽喉 | 53篇 |
儿科学 | 127篇 |
妇产科学 | 72篇 |
基础医学 | 575篇 |
口腔科学 | 136篇 |
临床医学 | 459篇 |
内科学 | 916篇 |
皮肤病学 | 115篇 |
神经病学 | 239篇 |
特种医学 | 101篇 |
外国民族医学 | 1篇 |
外科学 | 728篇 |
综合类 | 185篇 |
预防医学 | 472篇 |
眼科学 | 99篇 |
药学 | 504篇 |
中国医学 | 82篇 |
肿瘤学 | 406篇 |
出版年
2023年 | 69篇 |
2022年 | 224篇 |
2021年 | 354篇 |
2020年 | 198篇 |
2019年 | 175篇 |
2018年 | 211篇 |
2017年 | 147篇 |
2016年 | 174篇 |
2015年 | 197篇 |
2014年 | 240篇 |
2013年 | 282篇 |
2012年 | 407篇 |
2011年 | 411篇 |
2010年 | 186篇 |
2009年 | 164篇 |
2008年 | 259篇 |
2007年 | 235篇 |
2006年 | 211篇 |
2005年 | 186篇 |
2004年 | 160篇 |
2003年 | 131篇 |
2002年 | 119篇 |
2001年 | 66篇 |
2000年 | 59篇 |
1999年 | 44篇 |
1998年 | 16篇 |
1997年 | 23篇 |
1996年 | 18篇 |
1995年 | 23篇 |
1994年 | 8篇 |
1993年 | 12篇 |
1992年 | 26篇 |
1991年 | 22篇 |
1990年 | 18篇 |
1989年 | 14篇 |
1988年 | 16篇 |
1987年 | 10篇 |
1986年 | 8篇 |
1985年 | 11篇 |
1984年 | 13篇 |
1983年 | 16篇 |
1982年 | 8篇 |
1981年 | 5篇 |
1979年 | 17篇 |
1978年 | 5篇 |
1977年 | 7篇 |
1975年 | 14篇 |
1974年 | 9篇 |
1971年 | 5篇 |
1970年 | 5篇 |
排序方式: 共有5270条查询结果,搜索用时 0 毫秒
41.
42.
43.
44.
45.
Vascular endothelial growth factor (VEGF) is a potent angiogenesis mediator. Scant reports are available defining the role of VEGF in active and inactive tubercular meningitis (TBM) with no studies on brain tuberculoma. We quantified VEGF levels by enzyme linked immunoassay (ELISA) in cerebrospinal fluid (CSF) and serum in 20 cases each with active and inactive TBM as well as 22 cases of intraparenchymal tuberculoma. VEGF expression and microvessel angiogenesis quantification was done in 7 cases where tuberculomas were excised. Significantly increased VEGF levels in CSF were found in active TBM cases (106.0+/-50.0 pg/ml) compared to inactive TBM cases (14.7+/-10.0 pg/ml) (p<0.001). Mean serum VEGF levels in active TBM, inactive TBM and tuberculoma were 694.93+/-820.66 pg/ml, 499.61+/-238.33 pg/ml and 541.0+/-389.0 pg/ml, respectively. Immunohistochemical staining of excised tuberculoma demonstrated high expression of VEGF in granulomatous areas with intense positivity in inflammatory mononuclear cells, Langhan's giant cells as well as reactive astrocytes and fibrocytes. A strong positive correlation was observed between microvessel density and VEGF expression. Serial decrease in serum VEGF levels was observed with increasing duration of therapy in tuberculoma. We conclude that increased CSF and serum VEGF levels are a measure of activity of the disease in neurotuberculosis and its gradual decrease over a period of time is probably an indicator of therapeutic response. 相似文献
46.
47.
48.
49.
Abdul Ahad Fahad I. Al-Jenoobi Abdullah M. Al-Mohizea Naseem Akhtar Mohammad Raish Mohd. Aqil 《Saudi Pharmaceutical Journal》2015,23(6):587-602
Hypertension is the most common cardiovascular disease worldwide. Moreover, management of hypertension requires long-term treatment that may result in poor patient compliance with conventional dosage forms due to greater frequency of drug administration. Although there is availability of a plethora of therapeutically effective antihypertensive molecules, inadequate patient welfare is observed; this arguably presents an opportunity to deliver antihypertensive agents through a different route. Ever since the transdermal drug delivery came into existence, it has offered great advantages including non-invasiveness, prolonged therapeutic effect, reduced side effects, improved bioavailability, better patient compliance and easy termination of drug therapy. Attempts were made to develop the transdermal therapeutic system for various antihypertensive agents, including β-blockers, an important antihypertensive class. β-blockers are potent, highly effective in the management of hypertension and other heart ailments by blocking the effects of normal amounts of adrenaline in the heart and blood vessels. The shortcomings associated with β-blockers such as more frequent dose administration, extensive first pass metabolism and variable bioavailability, make them an ideal candidate for transdermal therapeutic systems. The present article gives a brief view of different β-blockers formulated as transdermal therapeutic system in detail to enhance the bioavailability as well as to improve patient compliance. Constant improvement in this field holds promise for the long-term success in technologically advanced transdermal dosage forms being commercialized sooner rather than later. 相似文献
50.
Ibrahim A. Aljuffali Mohd. Abul Kalam Yasmin Sultana Ahamad Imran Aws Alshamsan 《Saudi Pharmaceutical Journal》2015,23(1):85-94
Quantitative determination of gatifloxacin in tablets, solid lipid nanoparticles (SLNs) and eye-drops using a very simple and rapid chromatographic technique was validated and developed. Formulations were analyzed using a reverse phase SUPELCO® 516 C-18-DB, 50306-U, HPLC column (250 mm × 4.6 mm, 5 μm) and a mobile phase consisting of disodium hydrogen phosphate buffer:acetonitrile (75:25, v/v) and with orthophosphoric acid pH was adjusted to 3.3 The flow rate was 1.0 mL/min and analyte concentrations were measured using a UV-detector at 293 nm. The analyses were performed at room temperature (25 ± 2 °C). Gatifloxacin was separated in all the formulations within 2.767 min. There were linear calibration curves over a concentration range of 4.0–40 μg.mL−1 and correlation coefficients of 0.9998 with an average recovery above 99.91%. Detection of analyte from different dosage forms at the same Rt indicates the specificity and stability of the developed method. 相似文献